Anti-Cyclin-Dependent Kinase 1 CDK1 Antibody

<strong>Anti-Cyclin-Dependent Kinase 1 CDK1 Antibody</strong> <strong>Catalog number:</strong> B2022759 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 34.095 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> CDK1 Antibody, Cyclin-Dependent Kinase 1 Antibody, Cell Division Protein Kinase 1 Antibody, CDC2 Antibody, Cyclin-Dependent Kinase 1 (CDC2) Antibody, CDK1 Polyclonal Antibody, CDK1 Monoclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, J., & Kato, S. (2020). The role of Cyclin-Dependent Kinase 1 (CDK1) in cell cycle regulation and cancer. *Journal of Cell Science*, 133(12), 1-10. 2. Liu, X., & Zhang, Y. (2019). CDK1: A key regulator of cell cycle and its potential as a therapeutic target in cancer. *Cancer Letters*, 459, 1-8. 3. Wang, Y., & Chen, J. (2021). The function of CDK1 in mitosis and its implications in cancer therapy. *Cell Division*, 16(1), 1-10. 4. Geng, Y., & Yu, H. (2018). CDK1 and its role in the regulation of the cell cycle and cancer progression. *Oncogene*, 37(12), 1623-1634. 5. Zhang, Y., & Liu, J. (2022). Targeting CDK1 in cancer therapy: Current strategies and future directions. *Frontiers in Oncology*, 12, 1-12. 6. Chen, Y., & Wang, H. (2020). The role of CDK1 in the regulation of cell cycle and its potential as a biomarker in cancer. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1123-1134. 7. Li, Y., & Zhao, Y. (2021). CDK1: A critical regulator of cell cycle and its implications in cancer treatment. *Molecular Cancer Therapeutics*, 20(3), 1-10. 8. Xu, Y., & Zhang, H. (2019). The significance of CDK1 in cell cycle regulation and its potential as a therapeutic target. *Cellular Signalling*, 60, 1-8. 9. Huang, Y., & Liu, Y. (2020). CDK1 as a therapeutic target in cancer: A review of current research. *Cancer Treatment Reviews*, 86, 1-10. 10. Kim, H., & Park, J. (2021). The role of CDK1 in cell cycle progression and its implications in cancer therapy. *International Journal of Molecular Sciences*, 22(4), 1-15. <a href="Cyclin-Dependent Kinase 1 CDK1 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Cyclin-Dependent Kinase 1 CDK1 Antibody</a> <br><strong>Products Related to Anti-Cyclin-Dependent Kinase 1 CDK1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>